Inovio Pharma
(INO)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 28,238 | 46,329 | 21,988 | 41,102 | 59,010 |
| Marketable Securities | 195,513 | 206,669 | 259,895 | 307,024 | 301,384 |
| Receivables | 5,035 | 11,738 | 10,081 | 11,372 | 7,491 |
| TOTAL | $233,896 | $315,243 | $350,208 | $416,185 | $399,907 |
| Non-Current Assets | |||||
| PPE Net | 6,983 | 7,728 | 15,588 | 16,213 | 16,697 |
| Investments And Advances | 2,624 | 2,007 | 2,130 | 2,435 | 3,369 |
| Intangibles | 12,561 | 12,643 | 12,763 | 12,882 | 13,013 |
| Other Non-Current Assets | 10,518 | 10,912 | 11,279 | 11,683 | 12,525 |
| TOTAL | $32,686 | $33,291 | $41,760 | $43,214 | $45,604 |
| Total Assets | $266,583 | $348,533 | $391,968 | $459,399 | $445,511 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 26,170 | 80,907 | 75,782 | 106,354 | 39,523 |
| Accrued Expenses | 5,796 | 10,594 | 13,486 | 10,123 | 11,828 |
| TOTAL | $55,151 | $96,868 | $94,915 | $131,064 | $59,360 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 4,211 | 2,563 | 2,827 | 11,850 | 5,336 |
| Other Non-Current Liabilities | 12,186 | 29,271 | 30,324 | 30,575 | 30,974 |
| TOTAL | $12,218 | $29,303 | $30,356 | $30,664 | $31,066 |
| Total Liabilities | $67,369 | $126,171 | $125,271 | $161,728 | $90,426 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 21,886 | 21,669 | 20,782 | 20,775 | 19,079 |
| Common Shares | 263 | 21 | 250 | 248 | 227 |
| Retained earnings | -1,528,497 | -1,487,848 | -1,433,385 | -1,395,601 | -1,287,103 |
| Other shareholders' equity | -583 | -698 | -885 | -649 | -459 |
| TOTAL | $199,214 | $222,363 | $266,697 | $297,671 | $355,085 |
| Total Liabilities And Equity | $266,583 | $348,533 | $391,968 | $459,399 | $445,511 |